-+ 0.00%
-+ 0.00%
-+ 0.00%

ABL Diagnostics Shareholders Approve Name Change; Euronext Paris Listing to Remain

MT Newswires·09/18/2026 00:38:00
Listen to the news
12:38 AM EDT, 09/18/2026 (MT Newswires) -- ABL Diagnostics (ABLD.PA) shareholders approved the proposed corporate name change to ABL Texcell Diagnostics at an extraordinary general meeting held on Thursday, according to a same-day release. The new corporate name is intended to reflect the company's growth plans and its operations in molecular diagnostics, virology and life sciences. Meanwhile, the molecular diagnostics company's shareholders did not approve the transfer of ABL's listing to Euronext Growth Paris from the regulated market of Euronext Paris.